Exelixis Inc
(NAS:EXEL)
$
35.81
-0.04 (-0.11%)
Market Cap: 10.23 Bil
Enterprise Value: 9.24 Bil
PE Ratio: 22.96
PB Ratio: 4.50
GF Score: 91/100 Exelixis Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2022 / 05:30PM GMT
Release Date Price:
$19.22
(-1.28%)
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst
So good afternoon, everyone. I hope you're all doing well. I have the -- for those who don't know me, my name is Akash Tewari. I'm a biotech analyst here at Jefferies. I have the pleasure of hosting Mike Morrissey, President and CEO of Exelixis. Mike has been kind enough to join us even after going through ASCO, which I can't imagine would have pain that must have...
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
It's been a long week. Yes.
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst
It's been a long week for him, but he is nice enough to still join us. Mike, why don't I give it to you for just some brief introductory remarks, and then we can get into the space together.
Michael M. Morrissey;Akash Tewari
Exelixis, Inc. - CEO, President & Director;Jefferies LLC, Research Division
Thanks again for the invite. Good to see you again.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot